| 4.07 |  +0.01 / +0.25% |
Data as of 4:00pm ET | Day’s Change |
| 4.07 |  0.00 / 0.00% |
Volume: 13,000 |
| Previous close | 4.06 |
| Today’s open | 4.06 |
| Day’s range | 3.98 - 4.14 |
| Volume | 364,612 |
| Average volume (3 months) | 899,360 |
| Market cap | $543.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +52.63% |
| Earnings growth (this year) | -225.66% |
| Earnings growth (next 5 years) | -97.81% |
| Revenue growth (last year) | +902.20% |
| P/E ratio | NM |
| Price/Sales | 8.27 |
| Price/Book | 2.48 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGYPSynergy Pharmaceutic... | -0.23 | -4.43% |
| KERXKeryx Biopharmaceuti... | +0.11 | +1.39% |
| SGMOSangamo BioSciences ... | -0.02 | -0.25% |
| QLTIQLT Inc | +0.08 | +1.02% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $69.7M |
| Annual profit (last year) | -$32.4M |
| Net profit margin | -46.51% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Ronald C. Renaud, Jr., MBA |
Chief Financial Officer, Treasurer & Senior VP Daniella Beckman, CPA |
Corporate headquarters Cambridge, Massachusetts |
.
